A multifunctional ROS cascade nanoplatform enables common prosperity of O2 and H2O2 for magnetic targeting and fluorescence imaging-guided photodynamic/chemodynamic therapy
Linshan Jia,
No information about this author
Zimeng Zhou,
No information about this author
Xiaotong Li
No information about this author
et al.
Chemical Engineering Journal,
Journal Year:
2025,
Volume and Issue:
506, P. 160178 - 160178
Published: Jan. 1, 2025
Language: Английский
A Microneedle Patch Delivers Mitochondria‐ and Lysosomes‐ Dual Targeting Prodrug‐Like Photosensitizers with Regulated Photoactivity for Precise Photodynamic Therapy
Zheng Liu,
No information about this author
Zhimin Tang,
No information about this author
Ying Yin
No information about this author
et al.
Advanced Healthcare Materials,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 18, 2025
Antitumor
photodynamic
therapy
(PDT)
faces
huge
challenges
as
selectivity
and
phototoxic
damage,
requiring
delivery
photosensitizers
(PSs)
to
specifically
accumulate
in
tumors
even
organelle,
avoid
the
damage
during
delivery.
Herein,
a
microneedle
patch
(AIE-mito-TPP@MN)
containing
mitochondria-
lysosomes-
dual
targeting
prodrug-like
PSs
(AIE-mito-TPP/AlPcSNa4)
that
is
self-assembled
by
mitochondria-targeted
aggregation-induced-emission
molecule
(AIE-mito-TPP)
lysosome-targeted
aluminum
phthalocyanine
tetrasulfonate
(AlPcSNa4),
developed
achieve
cancer-cell-organelle-specific
for
precise
PDT
with
high
low
damage.
AIE-mito-TPP/AlPcSNa4
displays
activity
via
regulated
photoactivity
reduce
caused
"always
on"
PSs.
Meanwhile,
AIE-mito-TPP/AlPcSNa4@MN
can
insert
into
epidermis
rapid
tumor
lesion,
enhance
selective
accumulation
cells.
The
higher
lysosomal
acidity
cells
facilitates
disassembly
promotes
targeting.
Under
light
irradiation,
impairs
mitochondrial
function
induce
deeper
apoptosis
at
dose
(≈6
µg),
presenting
greater
therapeutic
efficacy
than
AIE-mito-TPP@MN,
AlPcSNa4@MN,
or
intravenous
injection.
Moreover,
presents
good
biocompatibility
lower
normal
cells,
well
of
Therefore,
organelle-targeting
possesses
great
potential
selectivity.
Language: Английский
Cascade-recharged macrophage-biomimetic ruthenium-based nanobattery for enhanced photodynamic-induced immunotherapy
Guoyu Xia,
No information about this author
Zhongxiong Fan,
No information about this author
Qi Wang
No information about this author
et al.
Journal of Nanobiotechnology,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: March 4, 2025
Photodynamic-induced
immunotherapy
(PDI)
is
often
hampered
by
low
reactive
oxygen
species
(ROS)
yield,
intra-tumor
hypoxia,
high
glutathione
(GSH)
concentration,
and
immunosuppressive
microenvironment.
In
view
of
this,
a
ruthenium
(Ru)-based
nanobattery
(termed
as
IRD)
with
cascade-charged
(O2),
ROS,
photodynamic-induced
coordination-driven
self-assembly
transition-metal
Ru,
photosensitizer
indocyanine
green
(ICG),
organic
ligand
dithiobispropionic
acid
(DTPA).
Then,
IRD
camouflaged
macrophage
membranes
to
obtain
IRD@M)
targeting
immune
evasion
capabilities.
Upon
intravenous
administration,
IRD@M
core-shell
structure,
nano
diameter,
good
stability
can
specifically
hoard
in
tumor
location
internalize
into
cells.
disassembly
triggered
GSH,
the
released
Ru³⁺
not
only
catalyzes
conversion
endogenous
hydrogen
peroxide
(H₂O₂)
O₂
alleviate
hypoxia
reduce
expression
hypoxia-inducible
factor-1α
(HIF-1α),
but
also
generates
hydroxyl
radicals
(·OH)
elevate
intracellular
ROS
levels.
This
process
significantly
enhances
photodynamic
therapy
(PDT)
efficacy
ICG.
Meanwhile,
DTPA
downregulate
overexpressed
GSH
elimination
deriving
from
PDT
exchange
reaction
thiol-disulfide
bond.
It
found
that
alleviating
hypoxic
microenvironment
synergistically
efficacy,
which
turn
cascades
recharge
subsequent
response,
improving
activating
systemic
tumor-specific
immunity.
Notably,
vitro
vivo
experimental
results
jointly
confirm
such
cascade-recharged
macrophage-biomimetic
Ru-based
achieve
an
obvious
while
minimized
side
effect.
Taken
together,
this
work
highlights
promising
strategy
for
simple,
flexible,
effective
immunogenic
cell
death
(ICD)
agents
within
PDI.
Language: Английский
Recent advances in nanomaterials for integrated phototherapy and immunotherapy
Coordination Chemistry Reviews,
Journal Year:
2025,
Volume and Issue:
535, P. 216608 - 216608
Published: March 27, 2025
Language: Английский
Optimizing mitochondrial-targeting groups of positively-charged BODIPY nanoparticles for enhanced photodynamic therapy
Huixuan Qi,
No information about this author
Ruobing Qu,
No information about this author
Jiaping Shen
No information about this author
et al.
Materials Chemistry Frontiers,
Journal Year:
2024,
Volume and Issue:
8(23), P. 3898 - 3905
Published: Jan. 1, 2024
1-Methylimidazole-modified
BODIPY
nanoprobes
were
developed
for
highly
efficient
mitochondrial
targeting
and
enhanced
photo
dynamic
therapy.
Language: Английский
Photoclick and Release for Spatiotemporally Localized Theranostics of Single Cells via In Situ Generation of 1,3‐Diaryl‐1H‐benzo[f]indazole‐4,9‐dione
Baolin Li,
No information about this author
Sitong Li,
No information about this author
Cefei Zhang
No information about this author
et al.
Angewandte Chemie,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 4, 2024
Abstract
Bioorthogonal
click‐release
chemistry
is
a
cutting‐edge
tool
for
exploring
and
manipulating
biomolecule
functions
in
native
biological
systems.
However,
it
challenging
to
achieve
the
precise
regulation
or
therapy
of
individual
cells
via
strategies
driven
by
proximity
thermodynamics.
Herein,
we
propose
novel
photoclick‐release
approach
based
on
photo‐induced
cycloaddition
between
4,4′‐bis(
N
‐arylsydnone)
C
‐bithienyl‐diarylsydnone
2‐arylamino‐naphthoquinone
irradiation
with
405
485
nm
light.
It
constructs
1,3‐diaryl‐1
H
‐benzo[
f
]indazole‐4,9‐dione
(BIZON)
as
pharmacophore
while
releases
an
arylamine
fluorescence
turn‐on
probing.
Both
photoclick
reagents
were
tailored
connecting
triphenyl
phosphonium
delivery
motif
enrichment
mitochondria
live
cells.
This
enables
intracellular
release
under
control
We
then
discovered
that
situ
photo‐generated
BIZON
capable
photosensitizing
upon
520
light
produce
singlet
oxygen
inside
aerobic
conditions.
Therefore,
realized
wash‐free
tracking
subsequent
anti‐cancer
efficacy
at
single‐cell
resolution
using
global
illumination,
which
provides
foundation
wavelength‐gated
theranostics.
Language: Английский
Photoclick and Release for Spatiotemporally Localized Theranostics of Single Cells via In Situ Generation of 1,3‐Diaryl‐1H‐benzo[f]indazole‐4,9‐dione
Baolin Li,
No information about this author
Sitong Li,
No information about this author
Cefei Zhang
No information about this author
et al.
Angewandte Chemie International Edition,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 4, 2024
Abstract
Bioorthogonal
click‐release
chemistry
is
a
cutting‐edge
tool
for
exploring
and
manipulating
biomolecule
functions
in
native
biological
systems.
However,
it
challenging
to
achieve
the
precise
regulation
or
therapy
of
individual
cells
via
strategies
driven
by
proximity
thermodynamics.
Herein,
we
propose
novel
photoclick‐release
approach
based
on
photo‐induced
cycloaddition
between
4,4′‐bis(
N
‐arylsydnone)
C
‐bithienyl‐diarylsydnone
2‐arylamino‐naphthoquinone
irradiation
with
405
485
nm
light.
It
constructs
1,3‐diaryl‐1
H
‐benzo[
f
]indazole‐4,9‐dione
(BIZON)
as
pharmacophore
while
releases
an
arylamine
fluorescence
turn‐on
probing.
Both
photoclick
reagents
were
tailored
connecting
triphenyl
phosphonium
delivery
motif
enrichment
mitochondria
live
cells.
This
enables
intracellular
release
under
control
We
then
discovered
that
situ
photo‐generated
BIZON
capable
photosensitizing
upon
520
light
produce
singlet
oxygen
inside
aerobic
conditions.
Therefore,
realized
wash‐free
tracking
subsequent
anti‐cancer
efficacy
at
single‐cell
resolution
using
global
illumination,
which
provides
foundation
wavelength‐gated
theranostics.
Language: Английский